Nevirapine Main Page

Medical Advocates
Nevirapine (Viramune)

Main Page

New and Noteworthy
Product Information
ARV Guidelines
Database of ARV Drug Interactions
Journal Data
Conference Data
Perinatal Data
Pediatric Data

ARV Main Page

Main New/Newsworthy

Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: February 04, 2012
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

February 2012

Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population
pharmacokinetics.
Svensson E, van der Walt JS, Barnes KI, et al Br J Clin Pharmacol. 2012 Feb 2.

Nevirapine (NVP) pharmacokinetics (PK) and risk of rash and hepatitis among HIV-infected Sub-Saharan
African Women.
Dong BJ, Zheng Y, Hughes MD, et alAIDS. 2012 Feb 1

Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz.
Kromdijk W, Mulder JW, Rosing H, et al J Antimicrob Chemother. 2012 Feb 1

January 2012

Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time a
fter perinatal single dose nevirapine.
Aizire J, McConnell MS, Mudiope P, et al J Acquir Immune Defic Syndr. 2012 Jan 1

ARV Main Page Main New/Newsworthy
Home Page

Nevirapine Main Page